A Post-Authorisation Safety Study (PASS) of ABRYSVO (Respiratory Syncytial Virus Stabilised Prefusion Subunit Vaccine) in Pregnant Women and their Offspring in a Real World Setting in Europe and UK (C3671026)

First published 13/01/2025

Last updated 06/11/2025

EU PAS number:

EUPAS1000000399

Study

Ongoing

Documents

Study protocol

Initial protocol

C3671026_RSV VACCINE MATERNAL PROTOCOL_V2.0_06AUG2024.pdf

English (1.83 MB - PDF) View document

Study results

Study report

c3671026-pass-progress-report1-report-body.pdf

English (800.29 KB - PDF) View document

C3671026_PROGRESS REPORT 1 UPDATED VERSION 2.0_03SEP2025.pdf

English (270.93 KB - PDF) View document

Other information

Secondary tabs